# Astrazeneca — media coverage

Astrazeneca was mentioned 78 times in 15 outlets across 5 countries over the last 12 months. 22% of that coverage was positive and 3% negative. 94% was editorial rather than PR or paid placement.

- Data as of: 2026-10-04 (window: last 365 days)
- Mentions (12 months): 78 (84 all-time)
- Outlets (12 months): 15 in 5 countries
- Average sentiment: +0.153 (22% positive, 3% negative)
- PR / editorial: 5 PR · 73 editorial
- Sector: Pharma

## Coverage over time (mentions per month)

| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 1 |
| 2026-01 | 3 |
| 2026-02 | 2 |
| 2026-03 | 0 |
| 2026-04 | 2 |
| 2026-05 | 12 |
| 2026-06 | 43 |
| 2026-07 | 1 |
| 2026-08 | 13 |
| 2026-09 | 0 |
| 2026-10 | 0 |

## Top outlets (12 months)

| Outlet | Mentions |
|---|---|
|  | 57 |
| astrazeneca.com | 6 |
| finance.yahoo.com | 2 |
| stocktitan.net | 2 |
| 29news.com | 1 |
| biospace.com | 1 |
| biospectrumindia.com | 1 |
| business-standard.com | 1 |

## Countries (12 months)

| Country | Mentions |
|---|---|
| US | 58 |
| INT | 14 |
| IN | 3 |
| GB | 2 |
| CN | 1 |

## Share of voice among Pharma peers (12 months)

| Brand | Mentions |
|---|---|
| Eli lilly | 130 |
| Astrazeneca | 78 |
| Pfizer | 64 |
| Johnson & johnson | 59 |
| Novo nordisk | 46 |
| Merck | 44 |
| Sandoz | 41 |
| Moderna | 38 |
| Bayer | 36 |
| Roche | 36 |

## Recent coverage

- [AstraZeneca new partner to WIN WIN Award - Cision News](https://news.cision.com/win-win-gothenburg-sustainability-award/r/astrazeneca-new-partner-to-win-win-award,c4389679) — news.cision.com, 2026-08-31, positive
- [Weekly Recap: Pipeline setbacks and Phase 3 TROPION-Urothelial04 launch - TradingView](https://www.tradingview.com/news/tradingview:8af267344e004:0-weekly-recap-pipeline-setbacks-and-phase-3-tropion-urothelial04-launch/) — tradingview.com, 2026-08-31, negative
- [What Is AstraZeneca (LSE:AZN) Signaling With Its Latest Late Stage Trial Results? - Yahoo Finance](https://finance.yahoo.com/healthcare/articles/astrazeneca-lse-azn-signaling-latest-021757962.html) — finance.yahoo.com, 2026-08-28, positive
- [AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis - BioSpace](https://www.biospace.com/drug-development/astrazeneca-amgen-notch-another-late-stage-win-for-tezspire-this-time-in-esophagitis) — biospace.com, 2026-08-27, positive
- [AstraZeneca growth spurs regional workforce push in Central Virginia - WVIR](https://www.29news.com/2026/08/27/astrazeneca-growth-spurs-regional-workforce-push-central-virginia/) — 29news.com, 2026-08-27, positive
- [AstraZeneca (AZN) Tezspire improves swallowing symptoms in Phase III trial - Stock Titan](https://www.stocktitan.net/sec-filings/AZN/6-k-astrazeneca-plc-current-report-foreign-issuer-5c94fd019e06.html) — stocktitan.net, 2026-08-27, positive
- [Daiichi Sankyo and AstraZeneca’s Datroway Enters Phase 3 Adjuvant Trial in High-Risk Muscle-Invasive Urothelial Cancer - Oncodaily](https://oncodaily.com/trial-updates/daiichi-sankyo-astrazeneca-574871) — oncodaily.com, 2026-08-26, positive
- [Executives from Lloyds, AstraZeneca and Shell will join ISG’s London AI summit - Stock Titan](https://www.stocktitan.net/news/III/isg-event-to-spotlight-strategies-for-the-ai-driven-autonomous-96lnrzw71zb9.html) — stocktitan.net, 2026-08-18, positive

Data: VoilàIQ, 2026-10-04. Canonical: https://voilaiq.com/brand-catalog/astrazeneca